# Denali Therapeutics Inc.: Form 8-K, filed Feb 16, 2024

- Company: [Denali Therapeutics Inc.](/companies/dnli.md) (CIK 1714899)
- Form: 8-K
- Filed: 2024-02-16
- Accepted by EDGAR: Feb 16, 2024, 08:02 ET
- Period: 2024-02-16
- Accession: 0001714899-24-000065
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1714899/000171489924000065/dnli-20240216.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1714899/000171489924000065/

## Items reported

- Item 7.01: Regulation FD disclosure

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1714899/000171489924000065/dnli-20240216.htm

Filed Feb 16, 2024.
Source: SEC EDGAR, the filing index for accession 0001714899-24-000065. Last ingested by Listed: Nov 3, 2026, 19:01 ET. No prices; not investment advice.